Immunology
News
COVID bivalent booster better vs. recent Omicron subvariants: Pfizer
An ongoing phase 2 trail shows the vaccine offered the strongest protection in people older than 55 years.
News
Evusheld PrEP may protect immunocompromised patients from severe COVID-19
Evusheld preexposure prophylaxis shows promise in protecting certain immunocompromised patients from severe COVID-19, Cleveland Clinic researchers...
Commentary
Is another COVID-19 booster really needed?
Vaccinate the elderly (and some middle aged too, if possible) and the frail as soon as possible with any version of the booster you have available...
News
When is an allergic reaction to raw plant food due to tree pollen?
Allergy tests may be needed for people who report atypical or severe reactions or who also react to cooked or processed plant foods.
News
Many young kids with COVID may show no symptoms
The relationship between symptoms and viral load also differed between adults and young children in a new study.
News
Evusheld for COVID-19: Lifesaving and free, but still few takers
“HHS hasn’t made a major educational effort to promote it.”
Conference Coverage
Fourth patient cleared of HIV after stem cell transplant for blood cancer
“Although a transplant is not an option for most people with HIV, these cases are still interesting, still inspiring, and help illuminate the...
News
COVID-19 often more severe with congenital heart defects
“Hospitalized patients with heart defects are up to twice as likely to have critical outcomes of COVID-19 illness,” says author of a new study.
News
AAP approves CDC’s child/adolescent vax schedule for 2022
A new vaccine has been added to the schedule.
News
New study shows natural immunity to COVID has enduring strength
“The study involved only the early COVID strains – it has no information on either the Delta or Omicron variants.”